This 2013 randomized phase II study evaluated the efficacy and safety of adding mistletoe extract (Iscador) to carboplatin-based chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC). The study found that patients receiving mistletoe extract experienced improved quality of life, including better emotional and functional well-being, compared to those receiving
